| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6114452 | Autoimmunity Reviews | 2015 | 10 Pages |
Abstract
Rituximab seems to be a safe and effective therapy for AIHA in this meta-analysis of observational studies. The authors suggest that it could be used at an earlier point in therapy, before more toxic immunosuppressive drugs, or in place of splenectomy in some cases.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Quitterie Reynaud, Isabelle Durieu, Marine Dutertre, Stanislas Ledochowski, Stéphane Durupt, Anne-Sophie Michallet, Denis Vital-Durand, Jean-Christophe Lega,